InMed Pharmaceuticals Inc. (INM)

NASDAQ: INM · Real-Time Price · USD

1.430

-0.030 (-2.05%)

At close: Aug 24, 2026, 4:00 PM EDT

1.450

+0.020 (1.40%)

After-hours: Aug 24, 2026, 7:31 PM EDT

InMed Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	4.94	4.94	4.6	4.14	1.09	-
Revenue Growth	285.22%	7.50%	11.18%	279.61%	-	-
Cost of Revenue	3.24	3.24	3.5	2.73	0.55	-
Gross Profit	1.71	1.71	1.1	1.4	0.54	-
Selling, General & Admin	6.71	6.56	5.8	5.85	6.67	4.48
Research & Development	2.83	2.85	3.22	3.73	7.28	5.34
Operating Expenses	9.75	9.62	9.24	9.78	14.14	9.94
Operating Income	-8.04	-7.92	-8.13	-8.38	-13.59	-9.94
Interest Expense	-0.02	-0.37	-	-	-	-
Interest & Investment Income	0.27	0.16	0.53	0.49	0.1	0.02
Currency Exchange Gain (Loss)	-0.04	-0.03	-0.06	-0.05	-0.12	-0.16
Other Non Operating Income (Expenses)	-	-	-	-	-	-0.12
EBT Excluding Unusual Items	-7.84	-8.16	-7.67	-7.93	-13.61	-10.2
Merger & Restructuring Charges	-	-	-	-	-0.2	-
Impairment of Goodwill	-	-	-	-	-2.02	-
Asset Writedown	-	-	-	-	-1.45	-
Other Unusual Items	-	-	-	-	-1.31	-
Pretax Income	-7.84	-8.16	-7.67	-7.93	-18.6	-10.2
Income Tax Expense	-	-	0.01	0.01	-	-
Net Income	-8.51	-8.16	-7.68	-7.95	-18.6	-10.2
Net Income to Common	-8.51	-8.16	-7.68	-7.95	-18.6	-10.2
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	3	1	0	0	0	0
Shares Outstanding (Diluted)	3	1	0	0	0	0
Shares Change	365.07%	156.13%	211.26%	336.59%	108.64%	28.72%
EPS (Basic)	-2.53	-8.36	-20.14	-64.92	-663.32	-759.16
EPS (Diluted)	-2.53	-8.36	-20.14	-64.92	-663.32	-759.16
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Free Cash Flow	-7.46	-7.77	-7	-7.45	-15.62	-9.79
Free Cash Flow Per Share	-2.22	-7.96	-18.36	-60.81	-557.14	-728.60
Gross Margin	34.53%	34.53%	23.95%	33.93%	49.89%	-
Operating Margin	-162.75%	-160.20%	-176.92%	-202.60%	-1247.60%	-
Profit Margin	-172.17%	-165.14%	-166.94%	-192.18%	-1707.32%	-
Free Cash Flow Margin	-150.88%	-157.14%	-152.14%	-180.02%	-1434.03%	-
EBITDA	-7.83	-7.71	-7.91	-8.18	-13.41	-9.82
EBITDA Margin	-158.51%	-155.89%	-172.15%	-197.71%	-	-
D&A For EBITDA	0.21	0.21	0.22	0.2	0.19	0.12
EBIT	-8.04	-7.92	-8.13	-8.38	-13.59	-9.94
EBIT Margin	-162.75%	-160.20%	-176.92%	-202.60%	-	-

SEC Filings: 10-K · 10-Q